홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
SNDX
#1700
Syndax Pharmaceuticals, Inc.
21.7
1
+6.89%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+6.89%
월간 변동
+1.92%
6달 변화
+32.54%
년간 변동율
+43.02%
이전 종가
20.3
1
Open
21.7
1
Bid
Ask
Low
21.7
1
High
21.7
1
양
124
마켓
주식
헬스케어
SNDX
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
85.57 M
86.02 M
86.05 M
86.14 M
86.91 M
88.2 M
—
Valuation ratios
Enterprise value
—
983.16 M
903.1 M
698.08 M
1.22 B
1.72 B
4.54 B
Price to earnings ratio
-5.27
-3.55
-3.19
-2.41
-4.27
-6.39
-16.26
Price to sales ratio
102.62
47.8
24.09
10.3
11.9
—
—
Price to cash flow ratio
-6.13
-4.12
-3.67
-2.66
-4.26
5.64
-4.96
Price to book ratio
0.84
3.93
0.81
0.78
1.71
28.16
31.45
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.2
0.13
0.13
0.12
0.11
0.13
0.49
Return on equity %
0.23
0.33
0.39
0.46
0.53
1.05
2.43
Return on invested capital %
678.91
—
183.19
177.62
182.98
248.51
792.31
Gross margin %
100
100
100
100
100
100
400
Operating margin %
716.62
1 254.75
417.91
182.71
125.19
91.34
817.14
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
673.01
1 226.16
423.34
189.28
132.36
99.32
844.3
Liquidity ratios
Quick ratio
—
5.82
5.75
4.55
4.42
4.12
18.85
Current ratio
6.99
5.82
5.8
4.71
4.64
4.4
19.55
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.03
0.01
0.03
0.06
0.08
0.13
0.3
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.46
-0.01
-0.01
-0.01
-0.01
-0.04
Long term debt to total equity ratio
—
1.15
-0.03
-0.04
-0.05
-0.09
-0.21
Per share metrics
Operating cash flow per share
0.73
0.67
1.1
1.02
0.81
0.8
3.74
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
4.56
6.69
5.94
5.27
5.03
4.55
20.8
Net current asset value per share
4.86
7.04
6.37
6.16
6.12
6.1
24.74
Tangible book value per share
4.29
3.37
2.5
1.82
1.33
0.75
6.4
Working capital per share
4.16
5.83
5.27
4.85
4.8
4.71
19.63
Book value per share
4.29
3.37
2.5
1.82
1.33
0.75
6.4
뉴스
Stifel, Syndax Pharmaceuticals 목표 주가 상향
Stifel raises Syndax Pharmaceuticals stock price target on drug sales
Syndax Pharmaceuticals, Inc. (SNDX) Q4 2025 Earnings Call Transcript
Syndax 2025년 4분기 실적 발표: 매출 50% 급증, 수익성 경로 제시
Syndax Q4 2025 slides: revenue surges 50%, profitability path outlined
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates
Syndax Pharmaceuticals Q4 실적 에상치보다 저조, 수익 예상치를 넘어
Syndax Pharmaceuticals earnings missed by $0.19, revenue topped estimates
Syndax, 암 치료제 출시 가속화 속 실적 시험대
Syndax faces earnings test as cancer drug launches accelerate
Syndax, Guggenheim 서밋에서 강력한 성장과 전략적 확장 강조
Syndax Pharmaceuticals' Early Launch Success Signals Continued Growth Into 2026 (NASDAQ:SNDX)